ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate1,2 short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.
The easy-to-implement solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.
ProFound AI Risk uniquely combines a range of risk factors, offering superior performance and accuracy in assessing short-term risk compared to traditional, commonly-used breast cancer risk models.1,2
Superior AccuracyUp to 2.4 times more
accurate than traditional
risk models1,2Simplified WorkflowEfficient and easy to implement solution provides a rapid short-term risk estimate based on the mammographic examPersonalized Care
Improved model delivers operational efficiency and enhances patient care
The latest generation of ProFound AI Risk offers unprecedented insights for clinicians and patients:
ProFound AI Risk offers the highest AUC available for providing a one-year future risk estimation based on a screening mammogram. This advanced solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier, when they may be more easily treated.
Risk Model Performance1,2
Relative AUC performance for traditional risk models compared to ProFound AI Risk for 2D Mammography and 3D mammography.
Uncertainties are given as the upper and lower 95% confidence intervals.
ProFound AI Risk software offers a practical approach to risk stratification that seamlessly integrates into the breast cancer screening process. All that is needed is a standard full field digital mammogram (FFDM) or combined digital breast tomosynthesis exam (DBT + 2D synthetic or 2D FFDM).
The easy to integrate ProFound AI Risk model offers superior accuracy1,2 and enables clinicians to truly personalize screening in order to find breast cancer early.
Results include the short-term breast cancer risk category [low, general, moderate and high].
Some women have a higher risk of developing breast cancer based on their geographical location and ancestry. With ProFound AI Risk, patient care has never been more personalized.
Specifically designed to factor in racial and ethnic backgrounds, ProFound AI Risk offers an equitable and inclusive approach to precision screening.3 The algorithm also factors in clinically relevant global screening guidelines and more than 15 country incidence and mortality reference tables, for alignment with that country’s general population.
ProFound AI Risk also includes multiple risk factors found in a screening mammogram:
AgeBreast Density
Subtle Mammographic Features
Ethnically-Inclusive Risk Assessment Matters
iCAD’s product portfolio offers innovative solutions to support breast cancer detection, measure breast density, assess personalized risk, and provide targeted radiation therapy. Our technologies offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes.
Thank you. An iCAD representative will contact you shortly.
References:
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.